These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 10614877)

  • 41. Differential androgen receptor signals in different cells explain why androgen-deprivation therapy of prostate cancer fails.
    Niu Y; Chang TM; Yeh S; Ma WL; Wang YZ; Chang C
    Oncogene; 2010 Jun; 29(25):3593-604. PubMed ID: 20440270
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Differential posttranscriptional regulation of androgen receptor gene expression by androgen in prostate and breast cancer cells.
    Yeap BB; Krueger RG; Leedman PJ
    Endocrinology; 1999 Jul; 140(7):3282-91. PubMed ID: 10385425
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Growth inhibition of human prostate cells in vitro by novel inhibitors of androgen synthesis.
    Klus GT; Nakamura J; Li JS; Ling YZ; Son C; Kemppainen JA; Wilson EM; Brodie AM
    Cancer Res; 1996 Nov; 56(21):4956-64. PubMed ID: 8895750
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Androgen action in the prostate gland.
    Yadav N; Heemers HV
    Minerva Urol Nefrol; 2012 Mar; 64(1):35-49. PubMed ID: 22402316
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Increased expression of androgen receptor sensitizes prostate cancer cells to low levels of androgens.
    Waltering KK; Helenius MA; Sahu B; Manni V; Linja MJ; Jänne OA; Visakorpi T
    Cancer Res; 2009 Oct; 69(20):8141-9. PubMed ID: 19808968
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Androgen sensitivity of prostate epithelium is enhanced by postnatal androgen receptor inactivation.
    Simanainen U; McNamara K; Gao YR; Handelsman DJ
    Am J Physiol Endocrinol Metab; 2009 Jun; 296(6):E1335-43. PubMed ID: 19366880
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pomegranate extracts impact the androgen biosynthesis pathways in prostate cancer models in vitro and in vivo.
    Ming DS; Pham S; Deb S; Chin MY; Kharmate G; Adomat H; Beheshti EH; Locke J; Guns ET
    J Steroid Biochem Mol Biol; 2014 Sep; 143():19-28. PubMed ID: 24565566
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Androgen Signaling in Esophageal Adenocarcinoma Cell Lines In Vitro.
    Palethorpe HM; Drew PA; Smith E
    Dig Dis Sci; 2017 Dec; 62(12):3402-3414. PubMed ID: 29052817
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The immunophilin ligands cyclosporin A and FK506 suppress prostate cancer cell growth by androgen receptor-dependent and -independent mechanisms.
    Periyasamy S; Warrier M; Tillekeratne MP; Shou W; Sanchez ER
    Endocrinology; 2007 Oct; 148(10):4716-26. PubMed ID: 17615153
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Androgen receptor-dependent regulation of Bcl-xL expression: Implication in prostate cancer progression.
    Sun A; Tang J; Hong Y; Song J; Terranova PF; Thrasher JB; Svojanovsky S; Wang HG; Li B
    Prostate; 2008 Mar; 68(4):453-61. PubMed ID: 18196538
    [TBL] [Abstract][Full Text] [Related]  

  • 51. An AKT activity threshold regulates androgen-dependent and androgen-independent PSA expression in prostate cancer cell lines.
    Paliouras M; Diamandis EP
    Biol Chem; 2008 Jun; 389(6):773-80. PubMed ID: 18627304
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Expression and function of normal and LNCaP androgen receptors in androgen-insensitive human prostatic cancer cells. Altered hormone and antihormone specificity in gene transactivation.
    Kokontis J; Ito K; Hiipakka RA; Liao S
    Receptor; 1991; 1(4):271-9. PubMed ID: 1668832
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dutasteride, the dual 5alpha-reductase inhibitor, inhibits androgen action and promotes cell death in the LNCaP prostate cancer cell line.
    Lazier CB; Thomas LN; Douglas RC; Vessey JP; Rittmaster RS
    Prostate; 2004 Feb; 58(2):130-44. PubMed ID: 14716738
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Transforming growth factor-beta1 induces nuclear to cytoplasmic distribution of androgen receptor and inhibits androgen response in prostate smooth muscle cells.
    Gerdes MJ; Dang TD; Larsen M; Rowley DR
    Endocrinology; 1998 Aug; 139(8):3569-77. PubMed ID: 9681509
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Androgen receptor as a regulator of ZEB2 expression and its implications in epithelial-to-mesenchymal transition in prostate cancer.
    Jacob S; Nayak S; Fernandes G; Barai RS; Menon S; Chaudhari UK; Kholkute SD; Sachdeva G
    Endocr Relat Cancer; 2014 Jun; 21(3):473-86. PubMed ID: 24812058
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Attenuation of androgenic regulation by brefeldin A in androgen-responsive prostate cancer cells.
    Alexander B; Fishman AI; Green D; Choudhury MS; Konno S
    Urol Oncol; 2013 Jan; 31(1):104-9. PubMed ID: 21795077
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Activation of dormant cancer cells in the prostates and seminal vesicles of Lobund-Wistar rats.
    Pollard M; Luckert PH
    Cancer Lett; 1994 Jul; 82(2):141-4. PubMed ID: 8050084
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The prognostic value of stromal FK506-binding protein 1 and androgen receptor in prostate cancer outcome.
    Leach DA; Trotta AP; Need EF; Risbridger GP; Taylor RA; Buchanan G
    Prostate; 2017 Feb; 77(2):185-195. PubMed ID: 27718274
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prevention of prostate-related cancers in Lobund-Wistar rats.
    Pollard M
    Prostate; 1999 Jun; 39(4):305-9. PubMed ID: 10344221
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Protective effect of γ-tocopherol-enriched diet on N-methyl-N-nitrosourea-induced epithelial dysplasia in rat ventral prostate.
    Sanches LD; Santos SA; Carvalho JR; Jeronimo GD; Favaro WJ; Reis MD; Felisbino SL; Justulin LA
    Int J Exp Pathol; 2013 Dec; 94(6):362-72. PubMed ID: 24205794
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.